Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.
- DOI
- 10.2174/0118715273427644251204045253
- Published
- 2026-05-22
- Container
- CNS Neurol Disord Drug Targets
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0118715273427644251204045253,
title = {Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.},
author = {Amin MA and Zehravi M and Sweilam SH and Darwin R and Gupta JK and Bhargav E and Dharmamoorthy G and Kumar VV and Rao AA and Suliman M and Periyasamy T and Emran TB.},
year = {2026},
journal = {CNS Neurol Disord Drug Targets},
doi = {10.2174/0118715273427644251204045253},
url = {https://doi.org/10.2174/0118715273427644251204045253}
}RIS
TY - JOUR TI - Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications. AU - Amin MA AU - Zehravi M AU - Sweilam SH AU - Darwin R AU - Gupta JK AU - Bhargav E AU - Dharmamoorthy G AU - Kumar VV AU - Rao AA AU - Suliman M AU - Periyasamy T AU - Emran TB. PY - 2026 JO - CNS Neurol Disord Drug Targets DO - 10.2174/0118715273427644251204045253 UR - https://doi.org/10.2174/0118715273427644251204045253 ER -
APA
MA, A., M, Z., SH, S., R, D., JK, G., E, B., G, D., VV, K., AA, R., M, S., T, P., & TB., E. (2026). Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications.. CNS Neurol Disord Drug Targets. https://doi.org/10.2174/0118715273427644251204045253
Source records
- europe-pmc · retrieved 2026-09-27T05:08:25.797Z